BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20250909T094206EDT-3569ZmN3M8@132.216.98.100 DTSTAMP:20250909T134206Z DESCRIPTION:October 4\, 2021\n 12:30 - 1:30 PM\n\nSEVENTH ANNUAL JGH DEPARTM ENT OF MEDICINE CLINICAL RESEARCH SYMPOSIUM\n\nI. DE-LABELING ANTIBIOTIC A LLERGY WITHOUT SKIN TESTING: AN UPDATE\n \n Jesse Schwartz\, MD\n Assistant P rofessor of Medicine\, 黑料社\n Division of Allergy and Immunolo gy\, Jewish General Hospital\n \n Educational Objectives:\n 1. Understand the risks and benefits of re-trying a medication after a patient has had an a dverse reaction\, with a focus on penicillin allergy\n 2. Provide an overvi ew of the DAAST study: De-labeling Antibiotic Allergy without Skin Testin \n\nII. PATIENT-LED REFERRAL FOR FAMILY MEMBERS AT THE TIME OF CARDIAC ICU ADMISSION\n \n Michael Goldfarb\, MD\, MSc\n Assistant Professor of Medicine \, 黑料社\n Division of Cardiology\, Jewish General Hospital\n \n Educational Objectives: \n 1. To describe a patient-initiated referral prog ram for family and household members at the time of a patient鈥檚 hospitaliz ation for acute coronary artery disease\n 2. To understand how a family-ori ented approach to primary cardiovascular prevention in family and househol d members can identify and improve cardiovascular\n\nIII. ONGOING TRIALS I N THE JGH DIALYSIS UNITS\n \n Daniel Blum\, MD\n Assistant Professor of Medic ine\, 黑料社\n Division of Nephrology\, Jewish General Hospital \n \n Educational Objectives: \n 1. Review the equipoise around anticoagulati on for stroke prophylaxis for atrial fibrillation among people receiving d ialysis: SAFE-D Trial\n 2. Review the equipoise around targeting low serum phosphate to improve cardiovascular outcomes among people receiving dialys is: PHOSPHATE Trial\n \n Contact Person: Vicky Tagalakis\, MD\, MSc\, Divisi on of Internal Medicine\, Tel. 514-340-7596.\n\n**\n \n October 11\, 2021\n \nNo Rounds - Thanksgiving\n\n**\n \n October 18\, 2021\n 12:30 - 1:30 PM\n\n A TRANSLATIONAL APPROACH TO BASAL CELL CARCINOMA \n \n Philippe Lefran莽ois\, MD\, PhD \n Assistant Professor of Medicine\, 黑料社\n Division of Dermatology\, Jewish General Hospital\n Investigator\, Lady Davis Instit ute for Medical Research\n \n Educational Objectives: \n 1. Understand the ep idemiology\, clinical features and dermoscopic features of basal cell carc inoma (BCC)\n 2. Explore the broad therapeutic modalities for BCC according to clinically-relevant features\n 3. Learn novel signalling pathways and a ctionable targets for BCC from cancer genomics\n \n Contact Person: Robin Bi llick\, MD\, Chief\, Division of Dermatology\, Tel. 514-340-8222 ext. 2506 5.\n\n**\n\nOctober 25\, 2021\n 12:30 - 1:30 PM\n \n UPDATE ON DELIRIUM AND T HE HOSPITAL ELDER LIFE PROGRAM (HELP) \n \n Fred H. Rubin\, MD\n Professor of Medicine\, Division of Geriatric Medicine\n University of Pittsburgh Schoo l of Medicine\n \n Educational Objectives:\n 1. Understand the criteria for d iagnosis of delirium and how to apply them in a clinical situation.\n 2. Re cognize the harms that delirium can cause\n 3. Appreciate that nearly half of all cases of delirium can be prevented\n \n Contact Person: Jos茅 Morais\, MD\, Chief\, Division of Geriatric Medicine\, Tel. 514-340-7501.\n\n\n Cli ck here for more info and the Microsoft Teams link.\n\n聽\n DTSTART;VALUE=DATE:20211004 DTEND;VALUE=DATE:20211025 SUMMARY:JGH Virtual Medical Grand Rounds - October 2021 URL:/medhealthsci/channels/event/jgh-virtual-medical-g rand-rounds-october-2021-333843 END:VEVENT END:VCALENDAR